The symposium focuses on the recent advances and discussion on strategies in transplant oncology topics such as hepatocellular carcinoma (HCC). Participants will gain knowledge through the in-depth sharing of clinical experience and best practices through our programme.
The Liver Transplant Symposium: Pushing Boundaries in Transplant Oncology |
Date | 23 and 24 September 2023, Saturday and Sunday |
Time | 8.30am to 5.30pm (Saturday), 8.30am to 12.30pm (Sunday) |
Venue | NUHS Tower Block Level 1 Auditorium 1E Kent Ridge Road, Singapore 119228 |
Who should attend? |
|
Category | Early Bird* | Standard Rate | |
---|---|---|---|
Individual | Groups of 5 and above | ||
Main Symposium only (Regular) | $260 | $380 | $200 |
Main Symposium only (Student rate) | $100 | $200 | $80 |
*Sign up by 1 September 2023 to enjoy early bird rates. Group discount will be given to groups of 5 and more.
CME/ CPE points will be awarded per day, per event.
Time | Session |
---|---|
8.30am | Welcome Address Prof Yeoh Khay Guan, Dr Mark Muthiah and Prof Shridhar Iyer Ganpathi |
8.40am | Plenary: Paradigm Shift in Transplant Oncology – The Road Ahead A/Prof Gonzalo Sapisochin Toronto General Hospital, Canada |
9.00am | Screening for HCC (Focusing on NASH) Dr Daniel Huang Qingyao National University Hospital, Singapore |
9.20am | Selecting the Ideal Candidate for Downstaging A/Prof Gonzalo Sapisochin Toronto General Hospital, Canada |
9.40am | Locoregional Strategies for Downstaging in HCC Prof Pierce Chow Kah Hoe National Cancer Centre Singapore |
10.00am | Systemic Therapy Including ICI to Downstage to Transplant in HCC Patients A/Prof Parissa Tabrizian The Mount Sinai Hospital, United States |
10.20am | Combined Q&A |
10.35am | Tea Break |
11.00am | Predicting Need for Transplantation in Resectable Candidates in HCC Dr Pang Ning Qi National University Hospital, Singapore |
11.20am | Tumour Thrombosis in HCC – Strategies for Success Dr Prashant Bhangui The Medanta Institute, India |
11.40am | How Far is Too Far in HCC for Liver Transplantation A/Prof Parissa Tabrizian The Mount Sinai Hospital, United States |
12.00pm | Small for Size and its Implications on Cancer and Recurrence Dr Prashant Bhangui The Medanta Institute, India |
12.20pm | Combined Q&A |
12.50pm | Lunch |
2.00pm | Identifying the Ideal Transplant Candidate for Colorectal Liver Metastasis A/Prof Glenn Kunnath Bonney National University Hospital, Singapore |
2.20pm | Chemotherapy Strategies Bridging to Transplantation Adj A/ Prof Chee Cheng Ean National University Cancer Institute Singapore |
2.40pm | Dealing with Recurrence after CRLM Liver Transplantation Prof Iain Tan Bee Huat National Cancer Centre Singapore |
3.00pm | Challenges and Regulatory Hurdles in Asia for CRLM Liver Transplantation A/Prof Dan Yock Young Deputy Director of Medical Services (DDMS) of the Ministry of Health (MOH), Singapore |
3.20pm | Combined Q&A |
3.35pm | Tea Break |
4.00pm | Liver Transplantation in Cholangiocarcinoma A/Prof Gonzalo Sapisochin Toronto General Hospital, Canada |
4.20pm | Paediatric Malignancies (Hepatoblastoma) Dr Amos Loh Hong Pheng KK Women’s and Children’s Hospital, Singapore |
4.40pm | Circulatory Strategies: VV Bypass and ECMO Dr Akila Rajakumar Rela Institute and Medical Centre, India |
5.00pm | Combined Q&A |
Time | Session |
---|---|
8.30am | The Future Roles of Systemic Therapy in Transplant Oncology A/Prof Parissa Tabrizian The Mount Sinai Hospital, United States |
8.50am | Immunosuppression Strategies for HCC Dr James Fung Yan Yue Queen Mary Hospital, Hong Kong |
9.10am | ICIs Application Before and After Liver Transplant: Where Are We? Dr He Kang Shanghai Jiaotong University School of Medicine |
9.30am | Systemic Chemotherapy for HCC Recurrence Post-Liver Transplantation Dr Choo Su Pin Curie Oncology, Singapore |
9.50am | Combined Q&A |
10.10am | Tea Break |
10.30am | Surgical and Interventional Strategies for HCC Recurrence A/Prof Shridhar Iyer National University Hospital, Singapore |
11.00am | Organ Support Strategies for ACLF: PLEX is the way to go Dr Anand V Kulkarni AIG Hospitals, India |
11.20am | Organ Support Strategies for ACLF: Non-PLEX based support systems Dr Lee Kang Hoe National University Singapore |
11.40am | Blood Group Incompatible Transplant in The Setting of Malignancy Dr James Fung Yan Yue Queen Mary Hospital, Hong Kong |
12.00pm | Combined Q&A |
12.20pm | Closing Speech |